- Home
- CHEB vs THTX Comparison
CHEB vs THTX Comparison
Compare CHEB & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEB
- THTX
- Stock Information
- Founded
- CHEB 2024
- THTX 1993
- Country
- CHEB Singapore
- THTX Canada
- Employees
- CHEB N/A
- THTX N/A
- Industry
- CHEB
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- CHEB
- THTX Health Care
- Exchange
- CHEB NYSE
- THTX Nasdaq
- Market Cap
- CHEB 122.8M
- THTX 118.2M
- IPO Year
- CHEB 2024
- THTX N/A
- Fundamental
- Price
- CHEB $10.45
- THTX $2.62
- Analyst Decision
- CHEB
- THTX Hold
- Analyst Count
- CHEB 0
- THTX 1
- Target Price
- CHEB N/A
- THTX N/A
- AVG Volume (30 Days)
- CHEB 50.2K
- THTX 6.2M
- Earning Date
- CHEB 01-01-0001
- THTX 04-09-2025
- Dividend Yield
- CHEB N/A
- THTX N/A
- EPS Growth
- CHEB N/A
- THTX N/A
- EPS
- CHEB N/A
- THTX N/A
- Revenue
- CHEB N/A
- THTX $88,666,000.00
- Revenue This Year
- CHEB N/A
- THTX N/A
- Revenue Next Year
- CHEB N/A
- THTX $15.13
- P/E Ratio
- CHEB N/A
- THTX N/A
- Revenue Growth
- CHEB N/A
- THTX 13.52
- 52 Week Low
- CHEB $9.30
- THTX $1.08
- 52 Week High
- CHEB $26.25
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- CHEB N/A
- THTX 57.56
- Support Level
- CHEB N/A
- THTX $2.64
- Resistance Level
- CHEB N/A
- THTX $2.82
- Average True Range (ATR)
- CHEB 0.00
- THTX 0.17
- MACD
- CHEB 0.00
- THTX -0.04
- Stochastic Oscillator
- CHEB 0.00
- THTX 20.45
About CHEB CHENGHE ACQUISITION II CO
Chenghe Acquisition II Co is a blank check company.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.